RNAZ logo

TransCode Therapeutics (RNAZ) Net Income

Annual Net Income

-$18.55 M
-$981.10 K-5.59%

01 December 2023

RNAZ Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Income

-$2.32 M
+$2.87 M+55.28%

01 September 2024

RNAZ Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Net Income

-$14.93 M
+$2.98 M+16.64%

01 September 2024

RNAZ TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RNAZ Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-+43.2%+19.5%
3 y3 years-171.0%+17.1%-118.1%
5 y5 years-2954.4%--

RNAZ Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-171.0%at lowat high+56.2%-156.1%+23.8%
5 y5 years-2954.4%at low-183.8%+56.2%<-9999.0%+23.8%
alltimeall time-2954.4%at low-183.8%+56.2%<-9999.0%+23.8%

TransCode Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sept 2024
-
-$2.32 M(-55.3%)
-$14.93 M(-16.6%)
June 2024
-
-$5.19 M(+56.0%)
-$17.91 M(+5.0%)
Mar 2024
-
-$3.33 M(-18.6%)
-$17.06 M(-8.0%)
Dec 2023
-$18.55 M(+5.6%)
-$4.09 M(-22.9%)
-$18.55 M(-5.3%)
Sept 2023
-
-$5.30 M(+22.1%)
-$19.59 M(+5.4%)
June 2023
-
-$4.34 M(-9.9%)
-$18.58 M(-1.7%)
Mar 2023
-
-$4.82 M(-6.2%)
-$18.91 M(+7.7%)
Dec 2022
-$17.57 M
-$5.13 M(+19.7%)
-$17.57 M(+15.3%)
Sept 2022
-
-$4.29 M(-8.2%)
-$15.23 M(+14.8%)
June 2022
-
-$4.67 M(+34.6%)
-$13.27 M(+127.7%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$3.47 M(+24.0%)
-$5.83 M(-14.8%)
Dec 2021
-$6.84 M(+192.0%)
-$2.80 M(+20.2%)
-$6.84 M(+41.2%)
Sept 2021
-
-$2.33 M(-184.1%)
-$4.85 M(+24.6%)
June 2021
-
$2.77 M(-161.8%)
-$3.89 M(-42.7%)
Mar 2021
-
-$4.49 M(+459.6%)
-$6.79 M(+189.6%)
Dec 2020
-$2.34 M(+286.0%)
-
-
Dec 2020
-
-$801.50 K(-41.7%)
-$2.34 M(+52.0%)
Sept 2020
-
-$1.37 M(+980.1%)
-$1.54 M(+815.4%)
June 2020
-
-$127.20 K(+208.0%)
-$168.50 K(+308.0%)
Mar 2020
-
-$41.30 K
-$41.30 K
Dec 2019
-$607.20 K
-
-

FAQ

  • What is TransCode Therapeutics annual net profit?
  • What is the all time high annual net income for TransCode Therapeutics?
  • What is TransCode Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for TransCode Therapeutics?
  • What is TransCode Therapeutics quarterly net income year-on-year change?
  • What is TransCode Therapeutics TTM net profit?
  • What is the all time high TTM net income for TransCode Therapeutics?
  • What is TransCode Therapeutics TTM net income year-on-year change?

What is TransCode Therapeutics annual net profit?

The current annual net income of RNAZ is -$18.55 M

What is the all time high annual net income for TransCode Therapeutics?

TransCode Therapeutics all-time high annual net profit is -$607.20 K

What is TransCode Therapeutics quarterly net profit?

The current quarterly net income of RNAZ is -$2.32 M

What is the all time high quarterly net income for TransCode Therapeutics?

TransCode Therapeutics all-time high quarterly net profit is $2.77 M

What is TransCode Therapeutics quarterly net income year-on-year change?

Over the past year, RNAZ quarterly net profit has changed by +$1.77 M (+43.21%)

What is TransCode Therapeutics TTM net profit?

The current TTM net income of RNAZ is -$14.93 M

What is the all time high TTM net income for TransCode Therapeutics?

TransCode Therapeutics all-time high TTM net profit is -$41.30 K

What is TransCode Therapeutics TTM net income year-on-year change?

Over the past year, RNAZ TTM net profit has changed by +$3.62 M (+19.52%)